Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
Fields of Study & Subjects
Microbial Natural Products and Biosynthesis
Phytochemical Studies and Bioactivities
Cancer therapeutics and mechanisms
Publication details
- Journal / source
- Med
- Publisher
- Elsevier BV
- Volume
- 7
- Issue
- 4
- Pages
- 101029–101029
- Publication date
- 19 February 2026
- Language
- EN